Sign-up for our newsletter
Pilot & Feasibility
Protocols & Methods
Reagents & Resources
Tissues & Samples
IMPC / KOMP Data
Pilot & Feasibility
University of Wyoming
Targeting Cathepsin K To Promote Diabetic Wound Healing
Non-healing wound affects ~25% of people with diabetes and represents a primary cause of ~85% of amputation of lower limbs, which is an enormous clinical problem and a substantial economic burden. There is a paucity of clinically approved agents that aid in the healing of diabetic wounds, warranting discovery and characterization of novel pharmacological targets for treating diabetic wounds. The development of chronic diabetic wounds is characterized by a highly proteolytic microenvironment or ‘catabolic state’. The elevated proteolytic activity leads to a continuous breakdown of the extracellular matrix proteins, sustaining a prolonged destructive state that delays wound healing. Collagen is the major extracellular matrix protein which plays a critical role in wound healing and is a major target for proteolysis. Wound dressings that modulate endogenous proteases by providing exogenous collagen as ‘suicide substrates’ have been developed as options to facilitate diabetic wounds. However, a more direct approach would be to inhibit the activity of the endogenous collagenase in the wound. Therefore, this project aims to evaluate the role of cathepsin K – the most potent mammalian collagenolytic and elastolytic enzyme known in diabetic wound healing. Preliminary studies presented here show that skin tissue from diabetic human subjects had lower levels of collagen and elevated levels of the cathepsin K compared to skin from nondiabetic humans. Furthermore, preliminary data demonstrate that cathepsin K is upregulated in diabetic wounds and that whole-body knockout of cathepsin K facilitates wound healing in a diabetic mouse model, which provide a strong rationale for this proposal. The objective of this application is to characterize the role of cathepsin K in diabetic wound healing and to determine the efficacy of targeting cathepsin K in facilitating healing. The overall hypothesis is that cathepsin K is detrimental to wound healing and inhibition of cathepsin K promotes wound healing. The following are the specific aims i) Determine the role of cathepsin K in diabetic wound healing in a clinically-relevant porcine model. ii) Validate the role of dysregulated cathepsin K in diabetic wound healing using recombinant cathepsin K and cathepsin K siRNA. The outcome of the proposed study will help identify and characterize cathepsin K as a potentially novel pharmacological target to promote healing of diabetic wounds, which remains a major unmet need.
No funding program application progress reports found.
No uploaded documents found.
No publications found.
No uploaded documents found.
No protocols found.
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
The DiaComp Cardiovascular Committee has the principal function of furthering the mission of the consortium with regard to diabetic cardiomyopathy and macrovascular disease.
Curation Flag Information
New comment to be added:
No experiments found.
No strains found.
No models found.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!